---
figid: PMC12178005__13045_2025_1717_Fig5_HTML
figtitle: Signal ways of diverse types of HA affecting tumor progression by regulating
  tumor immunity
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC12178005
filename: 13045_2025_1717_Fig5_HTML.jpg
figlink: /pmc/articles/PMC12178005/figure/F5/
number: F5
caption: Signal ways of diverse types of HA affecting tumor progression by regulating
  tumor immunity. High molecular weight HA (HMW HA) maintains ECM homeostasis and
  inhibits tumor metastasis. However, low molecular weight HA (LMW HA) not only remodels
  the ECM, induces immune response activation and signaling dysregulation, but also
  assists tumor cells in immune evasion. HMW HA inhibits the MAPK and NFκB signaling
  pathways and exhibits anti-inflammatory effects by producing IL-4 and IL-10. Moreover,
  MMP activation can be diminished by this pathway. The most common mechanism of HA
  remodeling the TME involves binding to CD44, which promotes the conversion of fibroblasts
  and macrophages to CAFs and TAMs, inhibiting the anti-tumor immune functions of
  NK and T cells. When LMW HA and Oliga HA bind to LYVE-1 and CD44, the MAPK/ERK and
  Akt pathways can be triggered. Therefore, ECM degradation and cancer cell proliferation
  are further promoted
papertitle: 'Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment
  to immunotherapy'
reftext: Qin Hu, et al. J Hematol Oncol. 2025;18(NA).
year: '2025'
doi: 10.1186/s13045-025-01717-y
journal_title: Journal of Hematology & Oncology
journal_nlm_ta: J Hematol Oncol
publisher_name: BMC
keywords: ''
automl_pathway: 0.8655629
figid_alias: PMC12178005__F5
figtype: Figure
redirect_from: /figures/PMC12178005__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12178005__13045_2025_1717_Fig5_HTML.html
  '@type': Dataset
  description: Signal ways of diverse types of HA affecting tumor progression by regulating
    tumor immunity. High molecular weight HA (HMW HA) maintains ECM homeostasis and
    inhibits tumor metastasis. However, low molecular weight HA (LMW HA) not only
    remodels the ECM, induces immune response activation and signaling dysregulation,
    but also assists tumor cells in immune evasion. HMW HA inhibits the MAPK and NFκB
    signaling pathways and exhibits anti-inflammatory effects by producing IL-4 and
    IL-10. Moreover, MMP activation can be diminished by this pathway. The most common
    mechanism of HA remodeling the TME involves binding to CD44, which promotes the
    conversion of fibroblasts and macrophages to CAFs and TAMs, inhibiting the anti-tumor
    immune functions of NK and T cells. When LMW HA and Oliga HA bind to LYVE-1 and
    CD44, the MAPK/ERK and Akt pathways can be triggered. Therefore, ECM degradation
    and cancer cell proliferation are further promoted
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR2
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - NFKB1
  - TLR4
  - IL10
  - IL4
  - MMP1
  - MMP2
  - MMP3
  - MMP7
  - MMP8
  - MMP9
  - MMP10
  - MMP11
  - MMP12
  - MMP13
  - MMP14
  - MMP15
  - MMP16
  - MMP17
  - MMP19
  - MMP20
  - MMP21
  - MMP23B
  - MMP24
  - MMP25
  - MMP26
  - MMP27
  - MMP28
  - CFAP97
  - LYVE1
  - CXCL8
  - IL1A
  - IL1B
  - KRAS
  - HRAS
  - NRAS
  - CD44
  - PTK2
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ITK
  - SLC22A3
  - TGFB1
  - TGFB2
  - TGFB3
  - SMAD3
  - CTNNB1
  - CD4
  - COL6A1
  - COL6A2
  - COL6A3
  - COL6A5
  - COL6A6
  - COL7A1
  - COL8A1
  - COL8A2
  - COL9A1
  - COL9A2
  - COL9A3
  - COL10A1
  - COL11A1
  - COL11A2
  - COL12A1
  - COL13A1
  - COL14A1
  - COL15A1
  - COL16A1
  - COL17A1
  - COL18A1
  - COL19A1
  - COL20A1
  - COL21A1
  - COL22A1
  - COL23A1
  - COL24A1
  - COL25A1
  - COL26A1
  - COL27A1
  - COL28A1
  - COL1A1
  - COL1A2
  - COL4A1
  - COL4A2
  - COL4A3
  - COL4A4
  - COL4A5
  - COL4A6
  - COL5A1
  - COL5A2
  - COL5A3
  - tlr2
  - il10
  - il13
  - il4
  - lyve1b
  - cxcl8a
  - rab1ab
  - mapk3
  - cd4-1
  - ptk2ab
  - mmp2
  - mmp9
  - smad3a
  - ctnnb1
  - ighv1-1
  - ROS
  - RAS
  - Collagen
  - cancer
  - Cancer
---
